3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Keratosis, Actinic
6
Carcinoma, Basal Cell
4
Uterine Cervical Dysplasia
3
Squamous Intraepithelial Lesions
2
HIV Infections
2
Condylomata Acuminata
2
Precancerous Conditions
1
Patient Satisfaction
1
Papillomavirus Infections
1
Paget Disease, Extramammary
1
Hutchinson's Melanotic Freckle
1
Carcinoma, Squamous Cell
1
Anus Neoplasms
1
Acquired Immunodeficiency Syndrome
1
Interventions
Radiotherapy
5
Mitomycin
5
Fluorouracil
5
Watchful Waiting
3
Paclitaxel
3
Nivolumab
3
Cisplatin
3
Vaccines
2
Radiation
2
Observation
2
Light Coagulation
2
Carboplatin
2
Capecitabine
2
pembrolizumab
1
nanocis
1
cemiplimab
1
atezolizumab
1
X-Rays
1
Vaccines, Synthetic
1
Technetium-99
1
Taxes
1
Specimen Handling
1
Sigmoidoscopy
1
Proctoscopy
1
Phantoms, Imaging
1
Papillomavirus Vaccines
1
Octreotide
1
Neoadjuvant Therapy
1
Mitomycins
1
Magnetic Resonance Spectroscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Anus Neoplasms
×
Imiquimod
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts